Skip to main navigation Skip to search Skip to main content

Use of Andexanet Alfa for Factor Xa Inhibitor Reversal in US Verified Trauma Centers: A National Survey

  • Charles Fasanya
  • , Abenámar Arrillaga
  • , Catherine Caronia
  • , Lauren Rothburd
  • , Tenzing Japhe
  • , Younghee Hahn
  • , Paul Joseph
  • , Dajana Reci
  • , Patricia Eckardt
  • Good Samaritan University Hospital
  • New York Institute of Technology College of Osteopathic Medicine

Research & Scholarship: Contribution to journalArticlepeer-review

Original languageEnglish
JournalClinical and Applied Thrombosis/Hemostasis
Volume30
DOIs
StatePublished - Jan 1 2024

ASJC Scopus Subject Areas

  • Hematology

Keywords

  • andexanet alfa
  • DOAC reversal
  • survey
  • trauma surgeons

Cite this